TipRanks
BeOne Medicines Ltd (HK:6160)
:6160
Hong Kong Market
6160
BeOne Medicines Ltd
RESEARCH TOOLSreports
Want to see HK:6160 full AI Analyst Report?

BeOne Medicines Ltd (6160) Ratios

26 Followers

BeOne Medicines Ltd Ratios

HK:6160's free cash flow for Q2 2026 was $0.90. For the 2026 fiscal year, HK:6160's free cash flow was decreased by $ and operating cash flow was $0.21. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 3.40 3.41 1.80 2.32 3.55
Quick Ratio
 3.06 3.08 1.58 2.09 3.35
Cash Ratio
 2.41 2.51 1.19 1.75 2.63
Solvency Ratio
 0.20 0.11 -0.18 -0.35 -0.97
Operating Cash Flow Ratio
 0.70 0.62 -0.06 -0.64 -1.02
Short-Term Operating Cash Flow Coverage
 7.80 19.71 -0.17 -1.68 -4.55
Net Current Asset Value
$ 3.21B$ 2.39B$ 1.40B$ 1.94B$ 3.21B
Leverage Ratios
Debt-to-Assets Ratio
 0.12 0.13 0.18 0.16 0.09
Debt-to-Equity Ratio
 0.22 0.25 0.32 0.26 0.14
Debt-to-Capital Ratio
 0.18 0.20 0.24 0.21 0.12
Long-Term Debt-to-Capital Ratio
 0.15 0.29 0.05 0.05 0.05
Financial Leverage Ratio
 1.77 1.89 1.78 1.64 1.46
Debt Service Coverage Ratio
 3.14 3.98 -0.60 -1.71 -5.37
Interest Coverage Ratio
 9.91 7.68 0.00 0.00 0.00
Debt to Market Cap
 0.03 0.06 0.05 0.05 0.02
Interest Debt Per Share
 0.85 0.81 0.79 0.69 0.45
Net Debt to EBITDA
 -3.58 -5.93 3.90 2.00 1.90
Profitability Margins
Gross Profit Margin
87.82%85.28%84.41%84.55%-36.09%
EBIT Margin
15.50%8.37%-14.91%-49.12%-126.40%
EBITDA Margin
18.03%11.02%-10.40%-45.55%-121.71%
Operating Profit Margin
15.06%8.37%-14.91%-49.12%-126.40%
Pretax Profit Margin
14.16%7.80%-13.99%-33.59%-138.50%
Net Profit Margin
10.70%5.37%-16.92%-35.86%-141.52%
Continuous Operations Profit Margin
10.70%5.37%-16.92%-35.86%-141.52%
Net Income Per EBT
75.53%68.83%120.97%106.77%102.18%
EBT Per EBIT
94.03%93.23%93.81%68.38%109.58%
Return on Assets (ROA)
7.14%3.49%-10.89%-15.19%-31.41%
Return on Equity (ROE)
14.22%6.59%-19.35%-24.93%-45.71%
Return on Capital Employed (ROCE)
13.07%6.99%-15.33%-30.23%-36.44%
Return on Invested Capital (ROIC)
9.58%4.76%-12.42%-25.67%-34.00%
Return on Tangible Assets
7.19%3.52%-11.13%-15.34%-33.06%
Earnings Yield
1.60%0.88%-3.35%-4.80%-8.70%
Efficiency Ratios
Receivables Turnover
 5.72 6.03 5.37 6.21 7.12
Payables Turnover
 1.59 1.64 1.47 1.21 6.54
Inventory Turnover
 1.02 1.30 1.20 0.91 6.82
Fixed Asset Turnover
 3.41 2.99 2.30 1.73 1.67
Asset Turnover
 0.67 0.65 0.64 0.42 0.22
Working Capital Turnover Ratio
 1.24 1.73 1.83 0.80 0.29
Cash Conversion Cycle
 192.19 120.34 123.22 155.81 48.94
Days of Sales Outstanding
 63.84 60.49 67.93 58.77 51.29
Days of Inventory Outstanding
 358.46 281.79 304.11 399.78 53.48
Days of Payables Outstanding
 230.12 221.94 248.82 302.74 55.84
Operating Cycle
 422.30 342.28 372.04 458.55 104.78
Cash Flow Ratios
Operating Cash Flow Per Share
 1.03 0.80 -0.10 -0.85 -1.12
Free Cash Flow Per Share
 0.91 0.67 -0.49 -1.29 -1.47
CapEx Per Share
 0.12 0.13 0.39 0.44 0.24
Free Cash Flow to Operating Cash Flow
 0.88 0.84 4.76 1.52 1.31
Dividend Paid and CapEx Coverage Ratio
 8.49 6.07 -0.27 -1.94 -4.60
Capital Expenditure Coverage Ratio
 8.49 6.07 -0.27 -1.94 -4.60
Operating Cash Flow Coverage Ratio
 1.30 1.03 -0.13 -1.24 -2.51
Operating Cash Flow to Sales Ratio
 0.24 0.21 -0.04 -0.47 -1.06
Free Cash Flow Yield
3.43%2.89%-3.48%-9.54%-8.53%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 62.04 115.16 -29.90 -20.84 -11.49
Price-to-Sales (P/S) Ratio
 6.25 6.10 5.05 7.47 16.27
Price-to-Book (P/B) Ratio
 7.91 7.49 5.77 5.20 5.25
Price-to-Free Cash Flow (P/FCF) Ratio
 29.14 34.63 -28.72 -10.48 -11.72
Price-to-Operating Cash Flow Ratio
 27.51 28.92 -136.77 -15.88 -15.39
Price-to-Earnings Growth (PEG) Ratio
 0.03 -0.81 1.08 0.37 -0.42
Enterprise Value Multiple
 31.07 49.45 -44.61 -14.41 -11.47
Enterprise Value
 34.30B 29.16B 17.69B 16.14B 19.76B
EV to EBITDA
 31.07 49.45 -44.61 -14.41 -11.47
EV to Sales
 5.60 5.45 4.64 6.56 13.96
EV to Free Cash Flow
 26.13 30.92 -26.41 -9.20 -10.05
EV to Operating Cash Flow
 23.05 25.82 -125.76 -13.94 -13.20
Tangible Book Value Per Share
 3.53 3.05 2.34 2.56 3.03
Shareholders’ Equity Per Share
 3.57 3.08 2.43 2.61 3.27
Tax and Other Ratios
Effective Tax Rate
 0.24 0.31 -0.21 -0.07 -0.02
Revenue Per Share
 4.22 3.77 2.78 1.81 1.06
Net Income Per Share
 0.45 0.20 -0.47 -0.65 -1.49
Tax Burden
 0.76 0.69 1.21 1.07 1.02
Interest Burden
 0.91 0.93 0.94 0.68 1.10
Research & Development to Revenue
 0.37 0.39 0.51 0.72 1.16
SG&A to Revenue
 0.36 0.38 0.48 0.00 0.00
Stock-Based Compensation to Revenue
 0.09 0.10 0.12 0.15 0.21
Income Quality
 2.27 3.93 0.22 1.31 0.75
Currency in USD